$21.98
0.78% yesterday
Nasdaq, Dec 20, 09:46 pm CET
ISIN
US71742Q1067
Symbol
PAHC

Phibro Animal Health Corporation Class A Stock price

$21.69
-1.70 7.27% 1M
+3.95 22.27% 6M
+10.11 87.31% YTD
+10.25 89.60% 1Y
+1.33 6.53% 3Y
-2.81 11.47% 5Y
-7.63 26.02% 10Y
Nasdaq, Closing price Fri, Dec 20 2024
-0.12 0.55%
ISIN
US71742Q1067
Symbol
PAHC
Sector
Industry

Key metrics

Market capitalization $878.52m
Enterprise Value $1.30b
P/E (TTM) P/E ratio 50.52
EV/FCF (TTM) EV/FCF 31.98
EV/Sales (TTM) EV/Sales 1.24
P/S ratio (TTM) P/S ratio 0.84
P/B ratio (TTM) P/B ratio 3.40
Dividend yield 2.21%
Last dividend (FY24) $0.48
Revenue growth (TTM) Revenue growth 7.17%
Revenue (TTM) Revenue $1.05b
EBIT (operating result TTM) EBIT $75.78m
Free Cash Flow (TTM) Free Cash Flow $40.67m
Cash position $89.84m
EPS (TTM) EPS $0.43
P/E forward 18.94
P/S forward 0.74
EV/Sales forward 1.10
Short interest 4.54%
Show more

Is Phibro Animal Health Corporation Class A a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,892 stocks worldwide.

Phibro Animal Health Corporation Class A Stock Analysis

Unlock Scores for Free

Analyst Opinions

5 Analysts have issued a Phibro Animal Health Corporation Class A forecast:

2x Hold
40%
3x Sell
60%

Analyst Opinions

5 Analysts have issued a Phibro Animal Health Corporation Class A forecast:

Hold
40%
Sell
60%

Financial data from Phibro Animal Health Corporation Class A

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
1,047 1,047
7% 7%
100%
- Direct Costs 717 717
6% 6%
69%
330 330
11% 11%
31%
- Selling and Administrative Expenses 217 217
16% 16%
21%
- Research and Development Expense - -
-
-
112 112
2% 2%
11%
- Depreciation and Amortization 36 36
5% 5%
3%
EBIT (Operating Income) EBIT 76 76
1% 1%
7%
Net Profit 17 17
16% 16%
2%

In millions USD.

Don't miss a Thing! We will send you all news about Phibro Animal Health Corporation Class A directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Phibro Animal Health Corporation Class A Stock News

Neutral
Seeking Alpha
about one month ago
Phibro Animal Health Corporation (NASDAQ:PAHC ) Q1 2025 Earnings Conference Call November 7, 2024 9:00 AM ET Company Participants Glenn David - Chief Financial Officer Jack Bendheim - Chairman-Board of Directors, President & Chief Executive Officer Daniel Bendheim - Director & Executive Vice President-Corporate Strategy Larry Miller - Chief Operating Officer Conference Call Participants Ekateri...
Neutral
Business Wire
about one month ago
TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its first quarter ended September 30, 2024, and its updated financial guidance for the year ending June 30, 2025. Highlights for the three months ended September 30, 2024 (compared to the three months ended September 30, 2023) Net sales of $260.4 mill...
Neutral
Business Wire
about 2 months ago
TEANECK, N.J.--(BUSINESS WIRE)--The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on December 18, 2024, to stockholders of record at the close of business on November 27, 2024. About Phibro Animal Health Corporation Phibro Animal Health Corporation is...
More Phibro Animal Health Corporation Class A News

Company Profile

Phibro Animal Health Corp. engages in the manufacture of animal health and mineral nutrition products. It operates through the following business segments: Animal Health, Mineral Nutrition, and Performance Products. The Animal Health segment develops, manufactures, and markets antibacterial, nutritional specialty products, and vaccines. The Mineral Nutrition segment comprises of the formulations and concentrations of trace minerals such as zinc, manganese, copper, iron, and compounds. The Performance Products segment offers production of specialty ingredients for use in the personal care, automotive, industrial chemical, and chemical catalyst industries. The company was founded on May 11, 1946 and is headquartered in Teaneck, NJ.

Head office United States
CEO Jack Bendheim
Employees 1,940
Founded 1946
Website www.pahc.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today